Rates of gout were also slightly higher 7.4% for GLP-1 users versus 6.6% for nonusers an increased risk about 12%
Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity
3.4 Complications and side effects of GLP-1 RAs Common side effects associated with GLP-1 receptor agonists (GLP-1 RAs) include gastrointestinal symptoms such as nausea (2560%), diarrhea, and vomiting (515%) (46)
Lauren Levy emphasizes starting preventive measures before hair loss occurs
By contrast, MACE risk was significantly lower among those who continued GLP-1RA use for 2 and 2.5 years, and lowest among those who maintained treatment for three years
The nurse, Abby, administering the IV was skilled and gentle, minimizing any discomfort
